Panacea Biotec Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Virtually debt-free
Concerns
- Currently loss-making (EPS ₹-1.3)
- Negative return on equity (ROE -2.4%)
- Negative return on capital (ROCE -2.4%)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
PANACEABIO · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 73.59% | 73.59% | 73.47% | 72.87% | 72.49% | 72.48% |
| FII | 0.26% | 0.27% | 0.26% | 0.37% | 0.38% | 1.16% |
| DII | 0.69% | 0.84% | 1.07% | 1.16% | 1.16% | 1.49% |
| Public | 25.46% | 25.30% | 25.21% | 25.60% | 25.96% | 24.86% |
Latest News
All newsPanacea Biotex bags new orders worth undisclosed value
*Panacea Biotec bags new orders worth undisclosed value.* The company announced receipt of contracts, signaling business growth. Such orders may boost near-term revenues and capacity utilization. Details on value and clients remain undisclosed. 📊 *STOCKS:* $PANACEABIO | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Orders
Panacea Biotec shares dematerialized in July 2026
*Panacea Biotec shares were dematerialized during July 2026.* This routine corporate action reflects standard share restructuring. No financial impact is expected from this update. 📊 *STOCKS:* $PANACEABIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dematerialization
Panacea Biotec shares dematerialized in June 2026
*Panacea Biotec shares dematerialized in June 2026* The company disclosed details of shares dematerialized during June 2026 as part of routine corporate filing. No financial impact is expected from this procedural update. Demat activity may signal shareholder restructuring but no **material** change in promoter stake reported. 📊 *STOCKS:* PANACEABIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Dematerialization
Panacea Biotex shares unchanged after newspaper publication notice
*Panacea Biotec shares unchanged after filing a copy of newspaper publication.* The notice is a routine regulatory disclosure with no operational or financial impact. **No material event or change** is indicated in the filing. Investors are advised to monitor for further updates. 📊 *STOCKS:* PANACEABIO | 🏢 *SECTOR:* Pharma | #LOWIMPACT #corporate